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Mechanism aside, the main point 
to appreciate is that the association 
of p120 with cadherin is truly the lim-
iting factor that determines whether a 
given cadherin molecule will persist on 
the cell surface or will be targeted for 
destruction. We know that cadherins 
are internalized by endocytosis when 
p120 dissociates from the juxtamem-
brane domain of cadherin (Figure 1) 
and that factors like clathrin and ubiq-
uitin ligase Hakai are likely players in 
the demise of p120-deprived cadherins 
(Davis et al., 2003; Xiao et al., 2003). 
We also know that α- and β-catenins 
are essentially irrelevant because they 
stay attached to cadherins and thus 
are internalized simultaneously.
What we don’t know is how these 
events unfold under normal circum-
stances in the cell. Presumably, the 
biophysical characteristics identified 
by Ishiyama et al. (2010) and described 
above do not alone drive cadherin turn-
over. If other mechanisms contribute, 
what might they look like? The simplest 
mechanism is shown in Figure 1 (right 
panel). In this model, p120 is modified, 
most likely by a kinase, in response to 
specific signals. Such a kinase could 
phosphorylate p120, the cadherin jux-
tamembrane domain, or both, result-
ing in separation of p120 from the 
complex and subsequent internaliza-
tion of cadherin. A second model (not 
shown) supposes that the role of p120 
is to recruit an additional factor to the 
cadherin complex, whose presence 
is required for cadherin retention and 
stability at the cell surface. In this sce-
nario, the absence of p120 leads to the 
loss of the stability factor, and the hap-
less cadherin is sacrificed due to lack 
of support. Both of these mechanisms 
might be tuned up or down as needed, 
but the relevant players have not been 
clearly identified.
The first visualization of p120’s molec-
ular makeup and its interaction with 
the cadherin juxtamembrane domain 
(Ishiyama et al., 2010) likely marks the 
beginning of a new generation of exper-
iments that will take advantage of these 
exquisite molecular insights. Minimally, 
the structure will lead to increasingly 
elegant reagents for selectively uncou-
pling distinct functions of p120 and 
improved interpretation of experimental 
results. However, given that the p120/
caderin interaction controls almost all of 
the classical cadherins and that p120 is 
frequently downregulated in most of the 
major cancers, the results presented by 
Ishimaya et al. (2010) will probably have 
far-reaching consequences.
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Optogenetic methods use light to modulate the activities of target cells in vivo. By improving 
inter- and intracellular trafficking of light-sensitive switch proteins called opsins, Gradinaru et al. 
(2010) have developed a new generation of optogenetic tools capable of regulating the activity of 
targeted neurons with exquisite precision and efficiency.Switching a well-defined cell population 
on and off at will is a desirable goal for 
systems biology research. Scientists 
have developed various methods across 
different species to target specific cells 
and make them controllable by diverse 22 Cell 141, April 2, 2010 ©2010 Elsevier Incexternal factors such as temperature 
and chemicals (Alexander et al., 2009; 
Liu and Davis, 2006). However, when it 
comes to temporal precision, literally 
nothing beats the speed of light. The 
successful marriage of optical technolo-.gies with molecular genetics has resulted 
in the new kid on the techniques block: 
optogenetics. Optogenetics is a rapidly 
developing technique that is being used 
by neuroscientists to manipulate the 
activity of selected neuronal populations 
figure 1. Targeting specific neurons by Optogenetics
Neurons A and B are neighboring neurons of the same type, with axonal projections ending in different 
brain regions containing neurons C and D, respectively. A virus encoding a WGA-CRE fusion protein is 
taken up by the soma of neuron C and the fusion protein product WGA-CRE  trans-synaptically traffics 
into neuron A. Another virus coding for a CRE-dependent light-activated opsin effector was taken up 
by both neurons A and B because of their close spatial proximity. Only in neuron A, in the presence 
of WGA-CRE, is the construct processed and the final light-sensitive protein product (ChR2 or NpHR) 
made. Thus, neuron A is specifically labeled and can be distinguished from neuron B on excitation with 
the correct wavelength of light. Such optogenetic approaches can be used to manipulate the activity of 
a single neuron in a cell population in living animals with great precision.in living animals. Optogenetics combines 
tissue- and cell type-specific expression 
of light-sensitive proteins called opsins 
and advanced optical methods to reach, 
record, and control the activity of a spe-
cific cell population. In this issue, Gradi-
naru et al. (2010) unveil the next-genera-
tion optogenetics toolbox.
Originally identified in microbes, the 
light-sensitive proteins channelrhodop-
sin-2 (ChR2) from the alga Chlamy-
domonas reinhardtii and halorhodopsin 
(NpHR) from the archaeon Natron-
omonas pharaonis are two of the most 
commonly used tools in optogenetics 
(Zhang et al., 2007). Channelrhodop-
sin-2 is a cation channel that allows the 
influx of Na+ when illuminated by ?470 
nm blue light (Nagel et al., 2003), result-
ing in activation of the neurons ectopi-
cally expressing this molecule. Halorho-
dopsin (Duschl et al., 1990), on the other 
hand, is a chloride ion pump activated 
by ?580 nm yellow light, which inhibits 
the neurons expressing it. The functions 
of ChR2 and NpHR are complementary, 
which enables bidirectional control of 
neuronal activity. ChR2 is reasonably 
well tolerated by cells and is readily transported into the axons and dendrites 
of neurons. However, when the original 
version of NpHR was expressed at high 
levels in neurons, it formed aggregates 
that led to cellular toxicity manifested 
by intracellular blebs and the swelling 
of dendrites (Zhao et al., 2008). These 
difficulties greatly diminished the use-
fulness of the first generation NpHR 
protein as a light-sensitive switch. More 
recently, improvements have been made 
by grafting signal peptides from mam-
malian membrane receptors onto NpHR 
to enhance its membrane targeting 
and ER export, resulting in eNpHR2.0 
(Gradinaru et al., 2008). Nevertheless, 
eNpHR2.0’s inability to counter strong 
excitation of neurons still limited its 
application, leaving the inhibitory arm of 
optogenetics significantly weaker than 
the excitatory one.
Different groups have taken various 
paths to deal with this imbalance. For 
example, Chow et al. (2009) identified a 
different type of molecule, archaerho-
dopsin-3 (Arch) from the archaeon Halo-
rubrum sodomense. It is a proton pump 
activated by yellow-green light. Arch is 
capable of generating photocurrents Ceapproaching 900 pA, which represents a 
huge increase compared to the original 
version of NpHR (typically around 100 
pA), though the light power required to 
elicit this response (36 mW/mm2) is at the 
higher end permissible for in vivo experi-
ments. Instead of turning to a light-sen-
sitive protein from a new species, Deis-
seroth and colleagues (Gradinaru et al., 
2010) decided to tame the very beast of 
NpHR by disciplining it using the funda-
mental principles of eukaryotic protein 
trafficking. Their effort has paid off: the 
addition of the C-terminal trafficking 
signal from the potassium ion channel 
Kir2.1 gave birth to eNpHR3.0. This ver-
sion shows both dramatically improved 
localization to the plasma membrane 
and, more importantly, substantially 
enhanced inhibitory capacity—even 
with relatively weak illumination of 3.5 
mW/mm2, the resulting photocurrent 
exceeded 1 nA.
These quantitative changes also led 
to qualitative changes—the inhibition 
efficiency of the eNpHR3.0 is so high 
that it can be stimulated by suboptimal 
wavelengths (including far red/infrared), 
and this allows for full-spectrum control 
of neuronal activity. This is a double-
edged sword, however, when eNpHR3.0 
is used in concert with an excitatory 
switch to establish bidirectional con-
trol within a single cell. As the authors 
coexpressed ChR2 and eNpHR3.0 in 
the same neuron, they found that blue-
light stimulation of ChR2 also weakly 
activated eNpHR3.0, and vice versa. 
This resulted in a 40% decrease in peak 
currents for both excitation and inhibi-
tion when compared to cells express-
ing either molecule individually. Nev-
ertheless, eNpHR3.0 is a tremendous 
improvement over earlier versions, and 
the authors have successfully used it in 
combination with ChR2. It is likely that 
a combination of ChR2 and eNpHR3.0 
(or Arch) will be sufficient in many cases 
where bidirectional control of cell mem-
brane potential is desired.
A second major breakthrough for 
optogenetics described by Gradinaru, 
Deisseroth, and their colleagues con-
cerns an important objective of cur-
rent molecular genetic technology: 
how to precisely target the expression 
of effector proteins to a specific type 
of cell. For model organisms where ll 141, April 2, 2010 ©2010 Elsevier Inc. 23
molecular genetics is underdeveloped, 
such as primates, this is almost out 
of the question. Even for organisms 
with a good collection of transcrip-
tional promoters, such as mice and 
fruit flies, targeting a subpopulation of 
cells within a genetically and anatomi-
cally “homogeneous” cell population is 
a challenge. To address these issues, 
the authors resorted to trans-synaptic 
trafficking. They used two viruses: one 
encoding CRE recombinase fused to 
the transcellular tracer protein wheat 
germ agglutinin (WGA) and a second 
encoding a CRE-dependent opsin. 
They delivered these two viruses to a 
pair of remote but anatomically con-
nected brain regions in rats or mice, 
one virus each to one of the two 
regions, and successfully labeled and 
optically controlled the subpopulation 
of neurons with projections connect-
ing these two brain regions (Figure 1). 
This approach also raises an intrigu-
ing possibility that activation or inhibi-
tion may be targeted to specific axonal 
branches, rather than to the neuronal 
soma (cell body), potentially increasing 
the precision of optogenetic manipula-
tion. Overall, trans-synaptic labeling of 24 Cell 141, April 2, 2010 ©2010 Elsevier Inc
Cyclic di-GMP is the molecule of the 
moment in bacteriology. This ubiq-
uitous secondary messenger has 
been implicated in myriad processes 
from pathogenicity to synthesis of pili 
(hairlike appendages involved in bio-
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The speed of the bacterial flagel
motor. Two new studies, Boehm 
now show that cyclic di-GMP al
the cyclic di-GMP binding proteianatomically connected neurons with a 
WGA-CRE fusion protein enabled tar-
geting of specific neurons on the basis 
of their synaptic connection patterns, 
thus opening new doors for the precise 
manipulation of neural circuits.
These optogenetic techniques de-
scribed by Deisseroth and his team, as 
well as by others, provide powerful new 
tools for neuroscience research. Al-
though these methods based on light-
gated ion channels are effective only in 
cells (neurons, muscle, endocrine cells, 
etc.) that can be rendered excitable by 
these channels, some additional recent 
developments promise broadening of 
the range of target cell types that can 
be manipulated by optogenetics. For 
example, new light-sensitive G protein-
coupled receptors (dubbed optoXRs) 
have the potential to influence signal-
ing cascades in cell types other than 
neurons (Airan et al., 2009). Theoreti-
cally, light-gated calcium ion channels 
could also be useful, as calcium ions 
are a universal secondary messenger 
in all known cell types. Expanding op-
togenetic tools so that they can be ap-
plied more broadly is the goal of opto-
genetics 3.0 and beyond..
film production) (reviewed in Hengge, 
2009). Now two new papers, one in this 
issue of Cell (Boehm et al., 2010) and 
one in the upcoming issue of Molecular 
Cell (Paul et al., 2010), reveal the direct 
involvement of cyclic di-GMP in the 
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Cyclic di-GMP is synthesized from 
two molecules of GTP by diguanylate 
cyclase domains and is broken down 
by phosphodiesterase domains. The 
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